Amphastar Pharmaceuticals, Inc.AMPHNASDAQ

Revenue (LTM)

$720M

-1.7% YoY

Net Income (LTM)

$98M

-38.5% YoY

Free Cash Flow

$121M

Revenue CAGR (5Y)

+15.5%

Marginsimproving

FCF$0.1B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	438	499↑14.0%	644↑29.1%	732↑13.6%	720↓1.7%
Gross Profit	200	249↑24.6%	351↑41.1%	374↑6.5%	356↓4.8%
Operating Income	70	107↑53.8%	197↑83.2%	205↑4.3%	140↓31.7%
Net Income	62	91↑47.1%	138↑50.5%	160↑16.0%	98↓38.5%
EBITDA	112	146↑31.0%	240↑64.4%	277↑15.4%	149↓46.2%
EPS Diluted	1.25	1.74↑39.2%	2.60↑49.4%	3.06↑17.7%	2.03↓33.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	126	156↑23.5%	144↓7.6%	152↑5.1%	170↑12.2%
Total Current Assets	318	378↑18.9%	490↑29.4%	534↑9.1%	636↑19.1%
Total Assets	672	742↑10.5%	1,513↑103.9%	1,577↑4.3%	1,629↑3.3%
Total Current Liabilities	104	95↓8.6%	225↑137.6%	174↓22.9%	158↓9.0%
Total Liabilities	226	213↓5.6%	873↑309.5%	845↓3.2%	840↓0.6%
Total Equity	446	529↑18.7%	639↑21.0%	732↑14.5%	789↑7.7%
Total Debt	105	103↓2.0%	624↑507.9%	651↑4.3%	656↑0.8%
Net Debt	-22	-54↓146.7%	479↑995.7%	499↑4.1%	486↓2.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	98	89↓9.0%	184↑105.8%	213↑16.3%	156↓26.8%
Capital Expenditure	-27	-24↑12.5%	-38↓58.8%	-41↓7.5%	-35↑15.0%
Free Cash Flow	71	65↓7.6%	145↑123.1%	172↑18.6%	121↓29.7%
Stock-Based Comp	19	18↓4.4%	20↑13.3%	24↑20.4%	0
Net Change in Cash	32	30↓7.3%	-12↓139.7%	7↑162.0%	19↑153.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance